It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Autotransporters are the largest family of outer membrane and secreted proteins in Gram-negative bacteria. Most autotransporters are localised to the bacterial surface where they promote colonisation of host epithelial surfaces. Here we present the crystal structure of UpaB, an autotransporter that is known to contribute to uropathogenic E. coli (UPEC) colonisation of the urinary tract. We provide evidence that UpaB can interact with glycosaminoglycans and host fibronectin. Unique modifications to its core β-helical structure create a groove on one side of the protein for interaction with glycosaminoglycans, while the opposite face can bind fibronectin. Our findings reveal far greater diversity in the autotransporter β-helix than previously thought, and suggest that this domain can interact with host macromolecules. The relevance of these interactions during infection remains unclear.
Autotransporter proteins are localised to the bacterial surface and promote colonisation of host epithelial surfaces. Here, the authors present the crystal structure of autotransporter UpaB and show evidence for distinct binding sites for glycosaminoglycans and host fibronectin.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 La Trobe University, Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938)
2 The University of Queensland, School of Chemistry and Molecular Biosciences, and Australian Infectious Diseases Research Centre, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
3 Griffith University, School of Medical Science, and Menzies Health Institute Queensland, Gold Coast, Australia (GRID:grid.1022.1) (ISNI:0000 0004 0437 5432)
4 Australian Synchrotron, Macromolecular Crystallography, Clayton, Australia (GRID:grid.248753.f) (ISNI:0000 0004 0562 0567); Monash University, Department of Molecular Biology and Biochemistry, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
5 CSIRO, Molecular & Materials Modelling group Data61, Melbourne, Australia (GRID:grid.431777.1)
6 Australian Nuclear Science and Technology Organisation, Australian Centre for Neutron Scattering, Lucas Heights, Australia (GRID:grid.1089.0) (ISNI:0000 0004 0432 8812)
7 Northwestern University, High Throughput Analysis Laboratory and Department of Molecular Biosciences, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
8 Australian Synchrotron, Macromolecular Crystallography, Clayton, Australia (GRID:grid.248753.f) (ISNI:0000 0004 0562 0567)